Lipigon Pharmaceuticals AB (9RP) Income Statement

Last quarter (Q2 2025), Lipigon Pharmaceuticals AB's total revenue was kr-1.00K, a decrease of -100.01% from the same quarter last year. In Q2, Lipigon Pharmaceuticals AB's net income was kr-8.70M. See Lipigon Pharmaceuticals AB’s key income statements, including revenue, expenses, profit, and income.